LSTA FY 2015 Earnings — Lisata Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

LSTALisata Therapeutics, Inc.

$44M

FY 2015 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$22M+25.4% YoY

Gross Profit

$2M10.4% margin

Operating Income

-$52M-229.3% margin

Net Income

-$81M-359.7% margin

EPS (Diluted)

$-250.12

Cash Flow

Operating Cash Flow

-$39M

Free Cash Flow

-$42M

Stock-Based Comp.

$9,750

Balance Sheet

Total Assets

$57M

Total Liabilities

$34M

Stockholders' Equity

$24M

Cash & Equivalents

$20M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$22M	$18M	+25.4%
Gross Profit	$2M	$2M	+3.1%
Operating Income	-$52M	-$58M	+10.7%
Net Income	-$81M	-$55M	-47.4%